Description:This patent relates generally to the fields of neurology and the pharmacotherapy. In particular, the present invention provides methods of improving cognitive deficits which occur following stroke and other conditions which interfere with the brain receiving the necessary blood supply or oxygen.
Abstract:The present invention provides for methods of treating cognitive deficits resulting from interruption of blood supply and/or oxygen deficit by administering a therapeutically effective dose of a sulfonyl fluoride, such as methanesulfonyl fluoride and ethanesulfonyl fluoride. The underlying cause of the or oxygen deficit can be from stroke, trauma, carbon monoxide poisoning, and other poisonings. This method also includes co-administering with sulfonyl fluoride with a therapeutically effective dose of a second agent.
Issue Date: 12/31/2013
Application Date: 08/14/2002
Post Date: 03/02/2018
UTEP Docket No: 2002-003
